Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yoshiko Iwasaki-Ishizuka"'
Autor:
Hideyuki Yamato, Kiyoshi Kurokawa, Masafumi Fukagawa, Tomoko Nii-Kono, Yoshiko Iwasaki-Ishizuka
Publikováno v:
Nephrology Dialysis Transplantation. 20:1904-1911
Background. Adynamic bone disease (ABD), which is characterized by reduced bone formation and resorption, has become an increasingly common manifestation of bone abnormalities in patients with end-stage renal failure. It has been recognized that skel
Autor:
Hideyuki Yamato, Ikuko Ezawa, Yoshiko Iwasaki-Ishizuka, Masafumi Fukagawa, Kiyoshi Kurokawa, Hisashi Murayama
Publikováno v:
Life Sciences. 76:1721-1734
Menatetrenone (MK-4) is a vitamin K2 homologue that has been used as a therapeutic agent for osteoporosis in Japan. However, there is no far any reported evidence that MK-4 ameliorates a pre-existing condition of reduced bone mineral density (BMD) in
Autor:
Hideyuki Yamato, Ikuko Ezawa, Yoshiko Iwasaki-Ishizuka, Kei Takahashi, Masafumi Fukagawa, Hisashi Murayama, Kiyoshi Kurokawa, Masako Abe
Publikováno v:
Journal of Nutritional Science and Vitaminology. 49:256-261
Vitamin K2 (menaquinone) acts on the bone metabolism. Menatetrenon (MK-4) is a vitamin K2 homologue that has been used as a therapeutic agent for osteoporosis in Japan. Rat models of immobilization induced by sciatic neurectomy are characterized by t
Autor:
Yoshiko Iwasaki-Ishizuka, Hideyuki Yamato, Tomoko Nii-Kono, Kiyoshi Kurokawa, Masafumi Fukagawa
Publikováno v:
Nephrology Dialysis Transplantation; Sep2005, Vol. 20 Issue 9, p1904-1911, 8p